ARQT

ACLX ARQT Biotechnology BSX ELAN MASI RGEN SYK TMO Uncategorized WELL

Baron Health Care Fund adds TMO, ARQT, and ELAN; exits Cidara Therapeutics MASI among Q4 moves

Mar 6, 2026

ARQT Biotechnology The Alpha Analyst Uncategorized

Arcutis After The Double: Hypergrowth Peaks, Compounding Remains

Feb 20, 2026